Διαχείριση φαρμακευτικών προϊόντων υπό το πρίσμα της βιοοικονομίας

Χανιώτη, Ναυσικά

Management of pharmaceutical products under the aspect of bioeconomy

Master Thesis

Author

Χανιώτη, Ναυσικά

Date

2020-12

Advisor

Βοργιάς, Κωνσταντίνος

Keywords

Βιοοικονομία ; Βιοτεχνολογία ; Φαρμακευτικός κλάδος ; Φαρμακευτικά προϊόντα ; Βιοπροϊόντα ; Βιοφαρμακευτικές εταιρείες ; Βιομιμητική ; Φαρμακευτικά αρωματικά φυτά ; Αιθέρια έλαια ; Κάνναβη ; Φαρμακευτικά προϊόντα θαλάσσιας προέλευσης ; Καινοτομία ; Πανδημία COVID-19 ; Ελλάδα ; Bioeconomy ; Biotechnology ; Pharmaceutical industry ; Pharmaceutical products ; Bioproducts ; Biopharmaceutical companies ; Biomimicry ; Aromatic plants (AP) ; Essential Oils (EOs) ; Cannabis ; Marine origin pharmaceutical products ; Innovation ; COVID-19 pandemic ; Greece ; Βιώσιμη ανάπτυξη ; Κυκλική οικονομία ; Sustainable development ; Circular economy

Abstract

Through the development of life sciences, the concept of the ever-rising Bioeconomy emerged, a field with a strong scientific and socio-political character, that is inspired by the principles of Sustainable Development and the Circular Economy. Bioeconomy directly affects the pharmaceutical industry, as the two fields are strongly correlated, with Biotechnology as a common feature. The aim of this study is to map the initiatives, prospects, and future trends of Bioeconomy to the field of pharmaceutical products, but also to propose innovative strategies that will yield effective, competitive, and ecologically efficient bioproducts, both at a national and a global level. The research findings demonstrate the transition of the pharmaceutical industry from the existing model of the "blockbuster" companies to a more sustainable model of biopharmaceutical companies, that will incorporate the technologies of new biology and face the challenges of previous years. In addition, the tool of Biomimicry is used in the solution of complex technological problems and, thus, inspiration is taken from nature after a thorough study of the biological systems. At the same time, the use of herbal and marine originated products is proposed to secure sources of new raw materials, especially in the case of Greece, where they thrive. Aromatic plants and medicinal cannabis are distinguished for several important pharmacological properties, while the marine environment can be an excellent source for the generation of new products with a high innovation, due to the contribution of the Blue Bioeconomy. In fact, these approaches can make a significant contribution to managing the major contemporary issue of the COVID-19 pandemic. In conclusion, this analysis concludes that Bioeconomy can provide original and cost-effective alternatives, that will greatly evolve the pharmaceutical industry and create outlets for its problems. This is the first recorded case of systematic research of this kind on this subject in Greece.